Immunotherapy for glioblastoma well tolerated; survival gains observed
Friday, April 14, 2017 - 12:51
in Health & Medicine
A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers at the Duke Cancer Institute report.